Background: Neutrophil lymphocyte ratio (NLR) is an indicator of subclinical inflammation. Subclinical inflammation may be associated with increased cardiovascular risk. Raised NLR is associated with metabolic syndrome and is found to be a predictor of cardiovascular disorders. There are only few studies assessing the correlation between NLR and glycemic control. The aim of the present study is to investigate the relationship between NLR and glycemic control in type 2 diabetes patients.Methods: This observational study was conducted in Department of Medicine, Bangalore medical college. 100 patients diagnosed to have type 2 diabetes mellitus were assessed. They were divided into three groups based upon HbA1c levels: Group 1, HbA1c ≤7%; group 2, HbA1c 7-9%, and group 3, HbA1c>9%. Complete blood count and other relevant investigations were performed. SPSS software was used for statistical analysis. T test was used for continuous variables and chi square test for categorical variables. ANOVA test was used to compare three groups. A p value of <0.05 was considered statistically significant.Results: Out of 100 patients, the white blood cell count (WBC count) was higher in group 3 as compared to group 1 and group 2(p 0.008). Similarly, the absolute neutrophil count was higher in group 3 as compared to group 1 and group 2(p.017). The neutrophil lymphocyte ratio (NLR) was significantly higher in group 3 as compared with group 1 and group 2(p.009). NLR had a positive correlation with HbA1c and was found to be an independent predictor of poor glycemic control in patients with type 2 diabetes mellitusConclusions: Our study found a significant positive correlation between NLR and glycemic control. Increased NLR is associated with elevated HbA1c and poor glycemic control. Type 2 diabetes mellitus patients with raised NLR should be evaluated for cardiovascular, renal and ocular complications of diabetes.
Background: The objective of this study was to study the multiple clinical parameters in patients with VAP and to compare the 3 scores namely, APACHE II, SOFA and CPIS in predicting the treatment outcome of patients with ventilator associated pneumonia.Methods: It was a cross sectional observational study conducted on forty patients admitted in ICU between June 2018 and July 2019, who developed VAP after admission to ICU. Logistic regression analysis was applied to estimate the predictive ability of the APACHE II, SOFA and CPIS scoring systems in assessing VAP-related mortality. A p value of <0.05 was considered significant. All analyses were performed using SPSS software version 10.Results: The sample size in our study was 40 patients. The mean age of patients was 43.4±15.9. The mean duration of mechanical ventilation before VAP onset was 8±2 days. Klebsiella species was the most common organism isolated from ET aspirate. Of the three scores only APACHE II was independent predictor of the mortality in the logistic regression analysis.Conclusions: APACHE II score is better at predicting mortality in patients with VAP as compared to SOFA and CPIS scores. Age, co-morbidities, duration of ICU stay, time of acquiring VAP, multi organ dysfunction, need for ionotropes and multi drug resistant organisms play an important role in predicting the outcome of patients.
Background and Objectives: Diagnostic markers to detect diabetic nephropathy at the early stage are important as early intervention can slow the loss of kidney function. Currently, there are very few diagnostic markers available. Micro-albuminuria is an accepted sign of early renal injury. Measurement of other markers such as neutrophil gelatinase-associated lipocalin and cystatin C, etc., is costly, and their utility is still under the research. Diabetic nephropathy in type 2 diabetes mellitus is thought to have elevated cytokines. However, their measurement is not easy. Absolute neutrophil count (ANC) and neutrophil-lymphocyte ratio (NLR) can act as a surrogate marker for the same. There is limited research concerning the correlation between ANC, NLR, and diabetic nephropathy. ANC is a very simple and inexpensive laboratory parameter. There are only a few studies done previously studying the association between ANC and albuminuria in the Indian population with type 2 diabetes mellitus. Subjects and Methods: This cross-sectional study was conducted in the hospitals attached to Bangalore Medical College and Research Institute. One hundred and forty-five Type II diabetes patients who gave consent for the study and satisfy the inclusion criteria were included in the study. Data were collected using semi-structured questionnaire, clinical examination, and relevant investigations. Statistical analysis was performed using the SPSS software. P < 0.05 was considered statistically significant. Results: Among the 145 individuals in the study, the mean age of the study population was 53.33 years (standard deviation: 11.90). The female-to-male ratio is 1.01: 1. The mean duration of disease was 5.88 years. The average ANC and NLR was higher in patients with proteinuria as compared to those without proteinuria. P value was statistically significant. It was noted that the NLR progressively increased from KDIGO stage G2 to G4, and the P value was statistically significant at 0.001. Interpretation and Conclusion: The NLR and ANC were significantly higher in patients with micro-albuminuria and macro-albuminuria compared to patients without proteinuria. They are simple, cost-effective parameters and can be considered as a surrogate marker for the detection and prognostic purposes of diabetic nephropathy. We hope this study adds to the existing data on NLR and ANC which are less studied parameters and paves way to future, well-matched, prospective studies which may define more in detail about the temporal correlation between ANC, NLR, and diabetic nephropathy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.